Lilly licenses new Cialis use to Maryland firm
Eli Lilly and Co. has licensed the U.S. rights to commercialize its drug Cialis to treat high blood pressure in the pulmonary artery to United Therapeutics Corp., a Maryland-based biotech drug firm. Indianapolis-based Lilly will buy $150 million of United Therapeutics’ common stock, but also receive a $150 million upfront payment from United Therapeutics, according […]